secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2022-12-14T23:59:59+00:00
Accession:  0001437749-22-029080
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Isoray annual meeting adjourned; needs ~18.3M more votes for merger share increase
--------------------------------------------------------------------------------

- Annual meeting adjourned to Jan 12, 2023; Proposal 1 (increase authorized shares to 750M) for Viewpoint merger needs 18.3M more 'for' votes.
- Stockholders approved other merger-related proposals: NYSE American issuance, equity plan amendment to 46M shares, and director elections.
- Isoray entered new Cesium-131 supply contracts with Russian JSC Isotope for 2023 and 2024; prior agreement nearly maxed out.
- Board and ISS/Glass Lewis recommend voting 'for' Proposal 1; management calls vote critical for transformational merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774922029080/0001437749-22-029080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774922029080/isr20221213_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-029080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer